2005
DOI: 10.1016/j.ajog.2005.05.072
|View full text |Cite
|
Sign up to set email alerts
|

Inflammatory-mediated model of cerebral palsy with developmental sequelae

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
17
2

Year Published

2006
2006
2023
2023

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 26 publications
(21 citation statements)
references
References 28 publications
2
17
2
Order By: Relevance
“…At 4 months, there is no more locomotor dysfunction observable. These results suggest that motor disorders observed in the first weeks improve and confirm the results of two previous studies showing that initially observed motor disorders disappear with time [13,21]. The functional deficiency observed at different tasks is not permanent.…”
Section: Discussionsupporting
confidence: 81%
See 1 more Smart Citation
“…At 4 months, there is no more locomotor dysfunction observable. These results suggest that motor disorders observed in the first weeks improve and confirm the results of two previous studies showing that initially observed motor disorders disappear with time [13,21]. The functional deficiency observed at different tasks is not permanent.…”
Section: Discussionsupporting
confidence: 81%
“…In a schizophrenia model, maternal administration of LPS at 18 and 19 days of gestation increases motor disorders and reactivity induced by amphetamine injections in adulthood [19]. Two studies from the same group demonstrate opposite results depending on whether they induced acute (showing no behavioral phenotype) [20] or chronic (leading to developmental sequelae) [21] inflammation in the dam. Finally, maternal intrauterine endotoxin administration leads to early motor deficits in the newborn rabbit, resulting in a phenotype that resembles those found in cystic periventricular leukomalacia (PVL) and CP [22,23].…”
Section: Introductionmentioning
confidence: 99%
“…Studies of the effect of infective agents on brain function, however, are not entirely consistent, and there are recent reports of either no neonatal cerebral palsy phenotype associated with low-dose lipopolysaccharide administration [44 •• ], or an early abnormal phenotype, which then becomes compensated in adult rats [45]. These recent data highlight a lack of precise phenotypic characterization in some previous work, which may be important in determining the relevance of documentable [46] brain lesions.…”
Section: Experimental Studiesmentioning
confidence: 93%
“…Toso et al [19] used the rat model to explore the potential for inflammatory mediated CP. Using serial intracervical injections of lipopolysaccharide at the equivalents of 28-36 weeks in human pregnancy they showed biochemical evidence of oligodendrocyte damage and delay in some motor milestones.…”
Section: Infection Inflammation and Hypoxiamentioning
confidence: 99%